Page last updated: 2024-07-31 20:01:34
prolyl-glycyl-proline
Description
Pro-Gly-Pro : no description available [CHeBI]
Cross-References
Synonyms (5)
Synonym |
(2r)-1-[2-[[(2s)-pyrrolidine-2-carbonyl]amino]acetyl]pyrrolidine-2-carboxylic acid |
pro-gly-pro |
CHEBI:162325 |
prolyl-glycyl-proline |
l-prolyl-glycyl-l-proline |
Drug Classes (1)
Class | Description |
peptide | Amide derived from two or more amino carboxylic acid molecules (the same or different) by formation of a covalent bond from the carbonyl carbon of one to the nitrogen atom of another with formal loss of water. The term is usually applied to structures formed from alpha-amino acids, but it includes those derived from any amino carboxylic acid. X = OH, OR, NH2, NHR, etc. |
Research
Studies (85)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (4.71) | 18.2507 |
2000's | 26 (30.59) | 29.6817 |
2010's | 50 (58.82) | 24.3611 |
2020's | 5 (5.88) | 2.80 |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 6 (6.25%) | 6.00% |
Case Studies | 1 (1.04%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 89 (92.71%) | 84.16% |
Substance | Studies | Classes | Roles | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
enkephalin, leucine | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[[2-formamido-4-(methylthio)-1-oxobutyl]amino]propanoic acid | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-formylmethionylphenylalanine | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
substance p | | peptide | neurokinin-1 receptor agonist; neurotransmitter; vasodilator agent | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
enalkiren | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
kynostatin 272 | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
terlakiren | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
kni 102 | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pidotimod | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cefpimizole | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
aspoxicillin | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
pro-diazepam | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
moexipril | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
mci 9038 | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
leucylleucine | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
diprotin a | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fk 888 | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
calpain inhibitor 2 | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
formylmethionyl-leucyl-phenylalanine methyl ester | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
t-kinin | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
3-(n-maleimidopropionyl)biocytin | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cefbuperazone | | cephalosporin; peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
endothelin (16-21) | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-valyltryptophan | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
neurotensin (1-8) | | peptide zwitterion; peptide | human metabolite | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
alanylaspartic acid | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
fibrin | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
n-carbobenzoxyglycylproline | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
s-(4-azidophenacyl)glutathione | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
bq 485 | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
phenylalanine arginine beta-naphthylamide | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
teprotide | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ro 09-1437 | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[2-[[2-(cyclopentylamino)-2-oxo-1-pyridin-4-ylethyl]-(thiophen-2-ylmethyl)amino]-2-oxoethyl]-2-furancarboxamide | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[2-[1,3-benzodioxol-5-yl-[2-(cyclopentylamino)-2-oxo-1-pyridin-4-ylethyl]amino]-2-oxoethyl]-2-furancarboxamide | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[1-[(1-amino-4-methyl-1-oxopentan-2-yl)amino]-3-methyl-1-oxopentan-2-yl]carbamic acid tert-butyl ester | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-tert-butyl-N-[2-(tert-butylamino)-2-oxoethyl]-3-(3,4-dihydro-2H-quinolin-1-yl)propanamide | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[2-[1,3-benzodioxol-5-yl-[2-(tert-butylamino)-2-oxo-1-pyridin-4-ylethyl]amino]-2-oxoethyl]-2-furancarboxamide | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[2-(4-chloro-N-[2-(cyclohexylamino)-2-oxoethyl]anilino)-2-oxoethyl]-2-furancarboxamide | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[(2-acetamido-1-oxoethyl)amino]-3-phenylpropanoic acid ethyl ester | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
deltorphin | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
angiotensin iii, 5-ile- | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[2-[butyl-[2-(cyclopentylamino)-2-oxo-1-pyridin-4-ylethyl]amino]-2-oxoethyl]-2-thiophenecarboxamide | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[[2-(cyclohexylamino)-2-oxo-1-thiophen-2-ylethyl]-[1-oxo-2-[[oxo(thiophen-2-yl)methyl]amino]ethyl]amino]acetic acid ethyl ester | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
N-[2-[[2-(cyclohexylamino)-2-oxo-1-thiophen-2-ylethyl]-(2-methoxyethyl)amino]-2-oxoethyl]-2-furancarboxamide | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-hydroxy-1-[1-oxo-2-(phenylmethoxycarbonylamino)propyl]-2-pyrrolidinecarboxylic acid | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
4-hydroxy-1-[1-oxo-2-[[1-oxo-2-(phenylmethoxycarbonylamino)ethyl]amino]propyl]-2-pyrrolidinecarboxylic acid (phenylmethyl) ester | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
2-[(2-acetamido-1-oxoethyl)amino]-N-(4-methoxyphenyl)-2-(4-methylphenyl)acetamide | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
mureidomycin a | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
kallidin | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
delapril | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
delapril | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
(2R)-2-[[(2R,3R,4R)-2-amino-4-hydroxy-4-(5-hydroxy-2-pyridinyl)-3-methyl-1-oxobutyl]amino]-2-[(2S,3R,4S,5S)-5-(2,4-dioxo-1-pyrimidinyl)-3,4-dihydroxy-2-oxolanyl]acetic acid | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
enkephalin, ala(2)-mephe(4)-gly(5)- | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
l 685458 | | carbamate ester; monocarboxylic acid amide; peptide; secondary alcohol | EC 3.4.23.46 (memapsin 2) inhibitor; peptidomimetic | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
alvimopan anhydrous | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
leucokinin i | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
s-(1,2-dichlorovinyl)glutathione | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
cyanoginosin-la | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
(3aS,6aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]-1-oxopropyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrole-2-carboxylic acid | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
lenampicillin | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
glycyl-alanyl-leucine | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
leucyl-leucine-methyl ester | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
valyl-valyl-valine | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
(3S)-N-[2-(2,3-dihydro-1,4-benzodioxin-6-ylamino)-2-oxoethyl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ly 450139 | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
flag peptide | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
carbobenzoxy-leucyl-leucyl-norvalinal | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
l 692585 | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
deltorphin ii, ala(2)- | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
deltorphin i, ala(2)- | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
eledoisin | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
icg 001 | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
darinaparsin | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
ubenimex | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
rhizocticin a | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
(2S)-2-[[[1-[(2S)-3-methyl-2-[(4-methylphenyl)sulfonylamino]-1-oxobutyl]-4-piperidinyl]-oxomethyl]amino]-2-phenylacetic acid | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
(2R)-2-[[(3S)-3-acetamido-3-carboxy-1-oxopropyl]amino]pentanedioic acid | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
alamandine | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
(3S)-3-[[[(2S)-1-[(2S)-2-[[(4-amino-3-chlorophenyl)-oxomethyl]amino]-3,3-dimethyl-1-oxobutyl]-2-pyrrolidinyl]-oxomethyl]amino]-3-cyanopropanoic acid | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
tuftsin | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
microcystin | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
thiocoraline | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
glutamyl-valyl-glycine | | peptide | | 0 | 0 | | low | 0 | 0 | 0 | 0 | 0 | 0 |
Condition | Indicated | Studies | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
2019 Novel Coronavirus Disease | 0 | | 2021 | 2021 | 3.0 | low | 0 | 0 | 0 | 0 | 0 | 1 |
Ache | 0 | | 2018 | 2018 | 6.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
Acute Lung Injury | 0 | | 2021 | 2021 | 3.0 | low | 0 | 0 | 0 | 0 | 0 | 1 |
Acute Respiratory Distress Syndrome | 0 | | 2018 | 2018 | 6.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
Aggression | 0 | | 2018 | 2018 | 6.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
Airflow Obstruction, Chronic | 0 | | 2010 | 2019 | 10.6 | low | 0 | 0 | 0 | 2 | 3 | 0 |
Airway Hyper-Responsiveness | 0 | | 2018 | 2018 | 6.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
Airway Obstruction | 0 | | 2014 | 2014 | 10.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
Airway Remodeling | 0 | | 2018 | 2020 | 5.3 | low | 0 | 0 | 0 | 0 | 3 | 0 |
Allergic Reaction | 0 | | 2018 | 2018 | 6.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
Amnionitis | 0 | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
Analgesia, Congenital | 0 | | 2009 | 2009 | 15.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
Anasarca | 0 | | 2016 | 2016 | 8.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
Angiitis | 0 | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
Anoxemia | 0 | | 2006 | 2006 | 18.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
Anxiety | 0 | | 2004 | 2022 | 12.7 | low | 0 | 0 | 0 | 2 | 0 | 1 |
Apoplexy | 0 | | 2019 | 2019 | 5.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
Asthma | 0 | | 2014 | 2018 | 8.0 | low | 0 | 0 | 0 | 0 | 2 | 0 |
Asthma, Bronchial | 0 | | 2014 | 2018 | 8.0 | low | 0 | 0 | 0 | 0 | 2 | 0 |
Bacterial Pneumonia | 0 | | 2015 | 2015 | 9.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
Behavior Disorders | 0 | | 2006 | 2006 | 18.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
Blood Poisoning | 0 | | 2011 | 2011 | 13.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
Bowel Diseases, Inflammatory | 0 | | 2019 | 2019 | 5.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
Brain Ischemia | 0 | | 2005 | 2017 | 13.0 | low | 0 | 0 | 0 | 1 | 2 | 0 |
Bronchiolitis Obliterans | 0 | | 2009 | 2009 | 15.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
Bronchiolitis, Exudative | 0 | | 2009 | 2009 | 15.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
Burns, Chemical | 0 | | 2000 | 2006 | 21.7 | low | 0 | 0 | 1 | 2 | 0 | 0 |
Centriacinar Emphysema | 0 | | 2011 | 2019 | 9.0 | low | 0 | 0 | 0 | 0 | 2 | 0 |
Cerebral Infarction, Middle Cerebral Artery | 0 | | 2013 | 2013 | 11.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
Cerebral Ischemia | 0 | | 2005 | 2017 | 13.0 | low | 0 | 0 | 0 | 1 | 2 | 0 |
Chorioamnionitis | 0 | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
Chronic Disease | 0 | | 2008 | 2015 | 12.8 | low | 0 | 0 | 0 | 1 | 3 | 0 |
Chronic Illness | 0 | | 2008 | 2015 | 12.8 | low | 0 | 0 | 0 | 1 | 3 | 0 |
Chronic Lung Injury | 0 | | 2018 | 2018 | 6.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
Complications, Infectious Pregnancy | 0 | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
Cornea Injuries | 0 | | 2000 | 2000 | 24.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
Corneal Injuries | 0 | | 2000 | 2000 | 24.0 | low | 0 | 0 | 1 | 0 | 0 | 0 |
Corneal Ulcer | 0 | | 2001 | 2006 | 20.5 | low | 0 | 0 | 0 | 2 | 0 | 0 |
Cystic Fibrosis | 0 | | 2008 | 2020 | 10.0 | low | 0 | 0 | 0 | 1 | 1 | 0 |
Cystic Fibrosis of Pancreas | 0 | | 2008 | 2020 | 10.0 | low | 0 | 0 | 0 | 1 | 1 | 0 |
Degenerative Diseases, Central Nervous System | 0 | | 2021 | 2021 | 3.0 | low | 0 | 0 | 0 | 0 | 0 | 1 |
Delayed Effects, Prenatal Exposure | 0 | | 2006 | 2006 | 18.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
Depression | 0 | | 2008 | 2008 | 16.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
Disbacteriosis | 0 | | 2022 | 2022 | 2.0 | low | 0 | 0 | 0 | 0 | 0 | 1 |
Disease Models, Animal | 0 | | 2003 | 2021 | 12.4 | low | 0 | 0 | 0 | 4 | 5 | 1 |
Disease, Pulmonary | 0 | | 2011 | 2018 | 10.7 | low | 0 | 0 | 0 | 0 | 3 | 0 |
Edema | 0 | | 2016 | 2016 | 8.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
Elevated Cholesterol | 0 | | 2013 | 2013 | 11.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
Equine Diseases | 0 | | 2014 | 2014 | 10.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
Experimental Lung Inflammation | 0 | | 2010 | 2017 | 11.7 | low | 0 | 0 | 0 | 2 | 1 | 0 |
Eye Burns | 0 | | 2000 | 2006 | 21.7 | low | 0 | 0 | 1 | 2 | 0 | 0 |
Fetal Membranes, Premature Rupture | 0 | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
Gastric Ulcer | 0 | | 1999 | 2016 | 15.2 | low | 0 | 0 | 1 | 2 | 2 | 0 |
Gastritis | 0 | | 2015 | 2015 | 9.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
Haemophilus Infections | 0 | | 2015 | 2015 | 9.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
Hypercholesterolemia | 0 | | 2013 | 2013 | 11.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
Hyperhidrosis | 0 | | 2009 | 2009 | 15.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
Hyperidrosis | 0 | | 2009 | 2009 | 15.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
Hypersensitivity | 0 | | 2018 | 2018 | 6.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
Hypoxia | 0 | | 2006 | 2006 | 18.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
Infarction, Middle Cerebral Artery | 0 | | 2013 | 2013 | 11.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
Infections, Orthomyxoviridae | 0 | | 2010 | 2010 | 14.0 | low | 0 | 0 | 0 | 2 | 0 | 0 |
Infections, Pneumococcal | 0 | | 2010 | 2010 | 14.0 | low | 0 | 0 | 0 | 2 | 0 | 0 |
Infections, Ureaplasma | 0 | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
Inflammation | 0 | | 2006 | 2021 | 9.9 | low | 0 | 0 | 0 | 5 | 13 | 1 |
Inflammatory Bowel Diseases | 0 | | 2019 | 2019 | 5.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
Injuries | 0 | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
Innate Inflammatory Response | 0 | | 2006 | 2021 | 9.9 | low | 0 | 0 | 0 | 5 | 13 | 1 |
Keratitis | 0 | | 2008 | 2008 | 16.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
Keratitis, Ulcerative | 0 | | 2001 | 2006 | 20.5 | low | 0 | 0 | 0 | 2 | 0 | 0 |
Lung Diseases | 0 | | 2011 | 2018 | 10.7 | low | 0 | 0 | 0 | 0 | 3 | 0 |
Lung Injury, Acute | 0 | | 2021 | 2021 | 3.0 | low | 0 | 0 | 0 | 0 | 0 | 1 |
Mental Disorders | 0 | | 2006 | 2006 | 18.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
Neurodegenerative Diseases | 0 | | 2021 | 2021 | 3.0 | low | 0 | 0 | 0 | 0 | 0 | 1 |
Orthomyxoviridae Infections | 0 | | 2010 | 2010 | 14.0 | low | 0 | 0 | 0 | 2 | 0 | 0 |
Pain | 0 | | 2018 | 2018 | 6.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
Peritonitis | 0 | | 2007 | 2007 | 17.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
Pheochromocytoma | 0 | | 2015 | 2015 | 9.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
Pheochromocytoma, Extra-Adrenal | 0 | | 2015 | 2015 | 9.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
Pneumococcal Infections | 0 | | 2010 | 2010 | 14.0 | low | 0 | 0 | 0 | 2 | 0 | 0 |
Pneumonia | 0 | | 2010 | 2017 | 11.7 | low | 0 | 0 | 0 | 2 | 1 | 0 |
Pneumonia, Bacterial | 0 | | 2015 | 2015 | 9.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
Pneumonia, Pneumococcal | 0 | | 2015 | 2015 | 9.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
Pregnancy | 0 | | 2006 | 2017 | 12.5 | low | 0 | 0 | 0 | 1 | 1 | 0 |
Premature Rupture of Fetal Membranes | 0 | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
Primary Peritonitis | 0 | | 2007 | 2007 | 17.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
Protein Aggregation, Pathological | 0 | | 2021 | 2021 | 3.0 | low | 0 | 0 | 0 | 0 | 0 | 1 |
Pulmonary Disease, Chronic Obstructive | 0 | | 2010 | 2019 | 10.6 | low | 0 | 0 | 0 | 2 | 3 | 0 |
Respiratory Distress Syndrome | 0 | | 2018 | 2018 | 6.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
Rida | 0 | | 2008 | 2008 | 16.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
Sepsis | 0 | | 2011 | 2011 | 13.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
Stomach Ulcer | 0 | | 1999 | 2016 | 15.2 | low | 0 | 0 | 1 | 2 | 2 | 0 |
Stroke | 0 | | 2019 | 2019 | 5.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
Vasculitis | 0 | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
Wounds and Injuries | 0 | | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
ACTH(6-9)-Pro-Gly-Pro ameliorates anxiety-like and depressive-like behaviour and gut mucosal microbiota composition in rats under conditions of chronic restraint stress.Neuropeptides, , Volume: 93, 2022
Protective and therapeutic effects of glyprolines in psychoemotional stress induced by cholecystokinin-4 injection.Bulletin of experimental biology and medicine, , Volume: 145, Issue:3, 2008
Effect of peptide Pro-Gly-Pro on stress-induced behavioral changes in rats.Bulletin of experimental biology and medicine, , Volume: 138, Issue:1, 2004
An extracellular matrix fragment drives epithelial remodeling and airway hyperresponsiveness.Science translational medicine, , 08-22, Volume: 10, Issue:455, 2018
Airway collagen and elastic fiber content correlates with lung function in equine heaves.American journal of physiology. Lung cellular and molecular physiology, , Aug-01, Volume: 307, Issue:3, 2014
Semax, an analog of ACTHMolecular genetics and genomics : MGG, , Volume: 292, Issue:3, 2017
The effect of Semax and its C-end peptide PGP on the morphology and proliferative activity of rat brain cells during experimental ischemia: a pilot study.Journal of molecular neuroscience : MN, , Volume: 45, Issue:2, 2011
C-terminal Pro-Gly-Pro tripeptide in contrast to full-length neuropeptide semax exhibits no neuroprotective effect in experimental cerebral ischemia.Bulletin of experimental biology and medicine, , Volume: 139, Issue:4, 2005
[The effect of semax and its C-end peptide PGP on Vegfa gene expression in the rat brain during incomplete global ischemia].Molekuliarnaia biologiia, , Volume: 47, Issue:3
[The effect of semax and its C-end peptide PGP on expression of the neurotrophins and their receptors in the rat brain during incomplete global ischemia].Molekuliarnaia biologiia, , Volume: 45, Issue:6
The effect of semax and the C-terminal peptide PGP on expression of growth factor genes and receptors in rats under conditions of experimental cerebral ischemia.Doklady. Biochemistry and biophysics, , Volume: 422
[Effect of tripeptide Pro-Gly-Pro on rat brain transcriptome in focal ischemia].Molekuliarnaia biologiia, , Volume: 48, Issue:2
A Potential Role for Acrolein in Neutrophil-Mediated Chronic Inflammation.Inflammation, , Volume: 38, Issue:6, 2015
Targeting of a common receptor shared by CXCL8 and N-Ac-PGP as a therapeutic strategy to alleviate chronic neutrophilic lung diseases.European journal of pharmacology, , Sep-30, Volume: 667, Issue:1-3, 2011
A self-propagating matrix metalloprotease-9 (MMP-9) dependent cycle of chronic neutrophilic inflammation.PloS one, , Jan-13, Volume: 6, Issue:1, 2011
A novel proteolytic cascade generates an extracellular matrix-derived chemoattractant in chronic neutrophilic inflammation.Journal of immunology (Baltimore, Md. : 1950), , Apr-15, Volume: 180, Issue:8, 2008
Abnormal pro-gly-pro pathway and airway neutrophilia in pediatric cystic fibrosis.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, , Volume: 19, Issue:1, 2020
A novel proteolytic cascade generates an extracellular matrix-derived chemoattractant in chronic neutrophilic inflammation.Journal of immunology (Baltimore, Md. : 1950), , Apr-15, Volume: 180, Issue:8, 2008
L-arginine-threonine-arginine (RTR) tetramer peptide inhibits ulceration in the alkali-injured rabbit cornea.Cornea, , Volume: 25, Issue:10, 2006
Inhibitory effect of a complementary peptide on ulceration in the alkali-injured rabbit cornea.Investigative ophthalmology & visual science, , Volume: 42, Issue:12, 2001
Synthetic complementary peptides inhibit a neutrophil chemoattractant found in the alkali-injured cornea.Cornea, , Volume: 19, Issue:3, 2000
A mechanism for matrikine regulation in acute inflammatory lung injury.JCI insight, , 04-08, Volume: 6, Issue:7, 2021
Abnormal pro-gly-pro pathway and airway neutrophilia in pediatric cystic fibrosis.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, , Volume: 19, Issue:1, 2020
Proline-Glycine-Proline Peptides Are Critical in the Development of Smoke-induced Emphysema.American journal of respiratory cell and molecular biology, , Volume: 61, Issue:5, 2019
Benzyloxycarbonyl-proline-prolinal (ZPP): Dual complementary roles for neutrophil inhibition.Biochemical and biophysical research communications, , 10-01, Volume: 517, Issue:4, 2019
The neutrophil chemoattractant peptide proline-glycine-proline is associated with acute respiratory distress syndrome.American journal of physiology. Lung cellular and molecular physiology, , 11-01, Volume: 315, Issue:5, 2018
An extracellular matrix fragment drives epithelial remodeling and airway hyperresponsiveness.Science translational medicine, , 08-22, Volume: 10, Issue:455, 2018
The development of novel LTAScientific reports, , 03-17, Volume: 7, 2017
Matrikines are key regulators in modulating the amplitude of lung inflammation in acute pulmonary infection.Nature communications, , Sep-24, Volume: 6, 2015
A Potential Role for Acrolein in Neutrophil-Mediated Chronic Inflammation.Inflammation, , Volume: 38, Issue:6, 2015
Airway collagen and elastic fiber content correlates with lung function in equine heaves.American journal of physiology. Lung cellular and molecular physiology, , Aug-01, Volume: 307, Issue:3, 2014
Binding of Pro-Gly-Pro at the active site of leukotriene A4 hydrolase/aminopeptidase and development of an epoxide hydrolase selective inhibitor.Proceedings of the National Academy of Sciences of the United States of America, , Mar-18, Volume: 111, Issue:11, 2014
Cigarette smoke-induced collagen destruction; key to chronic neutrophilic airway inflammation?PloS one, , Volume: 8, Issue:1, 2013
Tripeptide Pro-Gly-Pro prevents disturbances in osmotic resistance of rat erythrocytes under conditions of inflammation.Bulletin of experimental biology and medicine, , Volume: 153, Issue:3, 2012
A self-propagating matrix metalloprotease-9 (MMP-9) dependent cycle of chronic neutrophilic inflammation.PloS one, , Jan-13, Volume: 6, Issue:1, 2011
Medicine. Neutrophils find smoke attractive.Science (New York, N.Y.), , Oct-01, Volume: 330, Issue:6000, 2010
A critical role for LTA4H in limiting chronic pulmonary neutrophilic inflammation.Science (New York, N.Y.), , Oct-01, Volume: 330, Issue:6000, 2010
A novel proteolytic cascade generates an extracellular matrix-derived chemoattractant in chronic neutrophilic inflammation.Journal of immunology (Baltimore, Md. : 1950), , Apr-15, Volume: 180, Issue:8, 2008
Matrix metalloproteinase-8 facilitates neutrophil migration through the corneal stromal matrix by collagen degradation and production of the chemotactic peptide Pro-Gly-Pro.The American journal of pathology, , Volume: 173, Issue:1, 2008
Reply to 'A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation'.Nature medicine, , Volume: 12, Issue:6, 2006
The multifaceted roles of the matrikine Pro-Gly-Pro in pulmonary health and disease.European respiratory review : an official journal of the European Respiratory Society, , Jun-30, Volume: 27, Issue:148, 2018
Targeting of a common receptor shared by CXCL8 and N-Ac-PGP as a therapeutic strategy to alleviate chronic neutrophilic lung diseases.European journal of pharmacology, , Sep-30, Volume: 667, Issue:1-3, 2011
Leukotriene A4 hydrolase: an anti-inflammatory role for a proinflammatory enzyme.Thorax, , Volume: 66, Issue:6, 2011
Medicine. Neutrophils find smoke attractive.Science (New York, N.Y.), , Oct-01, Volume: 330, Issue:6000, 2010
A critical role for LTA4H in limiting chronic pulmonary neutrophilic inflammation.Science (New York, N.Y.), , Oct-01, Volume: 330, Issue:6000, 2010
Medicine. Neutrophils find smoke attractive.Science (New York, N.Y.), , Oct-01, Volume: 330, Issue:6000, 2010
A critical role for LTA4H in limiting chronic pulmonary neutrophilic inflammation.Science (New York, N.Y.), , Oct-01, Volume: 330, Issue:6000, 2010
Feasibility and physiological relevance of designing highly potent aminopeptidase-sparing leukotriene A4 hydrolase inhibitors.Scientific reports, , 10-19, Volume: 7, Issue:1, 2017
A critical role for LTA4H in limiting chronic pulmonary neutrophilic inflammation.Science (New York, N.Y.), , Oct-01, Volume: 330, Issue:6000, 2010
Medicine. Neutrophils find smoke attractive.Science (New York, N.Y.), , Oct-01, Volume: 330, Issue:6000, 2010
Glyprolines exert protective and repair-promoting effects in the rat stomach: potential role of the cytokine GRO/CINC-1.Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, , Volume: 67, Issue:2, 2016
Correlation analysis of cytokine gene expression changes and antiulcer effects of Pro-Gly-Pro and N-Acetyl-Pro-Gly-Pro in experimental models of ulceration.Doklady. Biochemistry and biophysics, , Volume: 465, 2015
Effect of glyprolines on homeostasis of gastric mucosa in rats with stress ulcers.Bulletin of experimental biology and medicine, , Volume: 149, Issue:1, 2010
[Protective effect of the intraperitoneal and intragastric administration of PGP-peptide on ethanol-induced erosions and acetate-induced ulcers in rats].Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology, , Issue:4, 2004
[Protective effect of peptide PGP on gastric mucosa].Doklady Akademii nauk, , Volume: 368, Issue:5, 1999
[Effects of glyprolines on development and healing of acetate ulcers in rats].Patologicheskaia fiziologiia i eksperimental'naia terapiia, , Issue:2
Proline-Glycine-Proline Peptides Are Critical in the Development of Smoke-induced Emphysema.American journal of respiratory cell and molecular biology, , Volume: 61, Issue:5, 2019
The matrikine PGP as a potential biomarker in COPD.American journal of physiology. Lung cellular and molecular physiology, , Jun-01, Volume: 308, Issue:11, 2015
Cigarette smoke-induced collagen destruction; key to chronic neutrophilic airway inflammation?PloS one, , Volume: 8, Issue:1, 2013
A critical role for LTA4H in limiting chronic pulmonary neutrophilic inflammation.Science (New York, N.Y.), , Oct-01, Volume: 330, Issue:6000, 2010
Medicine. Neutrophils find smoke attractive.Science (New York, N.Y.), , Oct-01, Volume: 330, Issue:6000, 2010
Proline-Glycine-Proline Peptides Are Critical in the Development of Smoke-induced Emphysema.American journal of respiratory cell and molecular biology, , Volume: 61, Issue:5, 2019
The matrikine PGP as a potential biomarker in COPD.American journal of physiology. Lung cellular and molecular physiology, , Jun-01, Volume: 308, Issue:11, 2015
Cigarette smoke-induced collagen destruction; key to chronic neutrophilic airway inflammation?PloS one, , Volume: 8, Issue:1, 2013
Medicine. Neutrophils find smoke attractive.Science (New York, N.Y.), , Oct-01, Volume: 330, Issue:6000, 2010
A critical role for LTA4H in limiting chronic pulmonary neutrophilic inflammation.Science (New York, N.Y.), , Oct-01, Volume: 330, Issue:6000, 2010
Abnormal pro-gly-pro pathway and airway neutrophilia in pediatric cystic fibrosis.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, , Volume: 19, Issue:1, 2020
The multifaceted roles of the matrikine Pro-Gly-Pro in pulmonary health and disease.European respiratory review : an official journal of the European Respiratory Society, , Jun-30, Volume: 27, Issue:148, 2018
An extracellular matrix fragment drives epithelial remodeling and airway hyperresponsiveness.Science translational medicine, , 08-22, Volume: 10, Issue:455, 2018
An extracellular matrix fragment drives epithelial remodeling and airway hyperresponsiveness.Science translational medicine, , 08-22, Volume: 10, Issue:455, 2018
Airway collagen and elastic fiber content correlates with lung function in equine heaves.American journal of physiology. Lung cellular and molecular physiology, , Aug-01, Volume: 307, Issue:3, 2014
L-arginine-threonine-arginine (RTR) tetramer peptide inhibits ulceration in the alkali-injured rabbit cornea.Cornea, , Volume: 25, Issue:10, 2006
Inhibitory effect of a complementary peptide on ulceration in the alkali-injured rabbit cornea.Investigative ophthalmology & visual science, , Volume: 42, Issue:12, 2001
Synthetic complementary peptides inhibit a neutrophil chemoattractant found in the alkali-injured cornea.Cornea, , Volume: 19, Issue:3, 2000
Semax, an analog of ACTHMolecular genetics and genomics : MGG, , Volume: 292, Issue:3, 2017
The effect of Semax and its C-end peptide PGP on the morphology and proliferative activity of rat brain cells during experimental ischemia: a pilot study.Journal of molecular neuroscience : MN, , Volume: 45, Issue:2, 2011
C-terminal Pro-Gly-Pro tripeptide in contrast to full-length neuropeptide semax exhibits no neuroprotective effect in experimental cerebral ischemia.Bulletin of experimental biology and medicine, , Volume: 139, Issue:4, 2005
[Effect of tripeptide Pro-Gly-Pro on rat brain transcriptome in focal ischemia].Molekuliarnaia biologiia, , Volume: 48, Issue:2
[The effect of semax and its C-end peptide PGP on expression of the neurotrophins and their receptors in the rat brain during incomplete global ischemia].Molekuliarnaia biologiia, , Volume: 45, Issue:6
[The effect of semax and its C-end peptide PGP on Vegfa gene expression in the rat brain during incomplete global ischemia].Molekuliarnaia biologiia, , Volume: 47, Issue:3
The effect of semax and the C-terminal peptide PGP on expression of growth factor genes and receptors in rats under conditions of experimental cerebral ischemia.Doklady. Biochemistry and biophysics, , Volume: 422
A Potential Role for Acrolein in Neutrophil-Mediated Chronic Inflammation.Inflammation, , Volume: 38, Issue:6, 2015
Targeting of a common receptor shared by CXCL8 and N-Ac-PGP as a therapeutic strategy to alleviate chronic neutrophilic lung diseases.European journal of pharmacology, , Sep-30, Volume: 667, Issue:1-3, 2011
A self-propagating matrix metalloprotease-9 (MMP-9) dependent cycle of chronic neutrophilic inflammation.PloS one, , Jan-13, Volume: 6, Issue:1, 2011
A novel proteolytic cascade generates an extracellular matrix-derived chemoattractant in chronic neutrophilic inflammation.Journal of immunology (Baltimore, Md. : 1950), , Apr-15, Volume: 180, Issue:8, 2008
Abnormal pro-gly-pro pathway and airway neutrophilia in pediatric cystic fibrosis.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, , Volume: 19, Issue:1, 2020
A novel proteolytic cascade generates an extracellular matrix-derived chemoattractant in chronic neutrophilic inflammation.Journal of immunology (Baltimore, Md. : 1950), , Apr-15, Volume: 180, Issue:8, 2008
A mechanism for matrikine regulation in acute inflammatory lung injury.JCI insight, , 04-08, Volume: 6, Issue:7, 2021
An extracellular matrix fragment drives epithelial remodeling and airway hyperresponsiveness.Science translational medicine, , 08-22, Volume: 10, Issue:455, 2018
Semax, an analog of ACTHMolecular genetics and genomics : MGG, , Volume: 292, Issue:3, 2017
N-Acetylated Proline-Glycine-Proline Accelerates Cutaneous Wound Healing and Neovascularization by Human Endothelial Progenitor Cells.Scientific reports, , 02-23, Volume: 7, 2017
Activation of CXCR2 by extracellular matrix degradation product acetylated Pro-Gly-Pro has therapeutic effects against sepsis.American journal of respiratory and critical care medicine, , Jul-15, Volume: 184, Issue:2, 2011
Cigarette smoke-induced lung emphysema in mice is associated with prolyl endopeptidase, an enzyme involved in collagen breakdown.American journal of physiology. Lung cellular and molecular physiology, , Volume: 300, Issue:2, 2011
Myenteric neurons of the ileum that express somatostatin are a target of prion neuroinvasion in an alimentary model of sheep scrapie.Acta neuropathologica, , Volume: 115, Issue:6, 2008
L-arginine-threonine-arginine (RTR) tetramer peptide inhibits ulceration in the alkali-injured rabbit cornea.Cornea, , Volume: 25, Issue:10, 2006
[Protective effect of the intraperitoneal and intragastric administration of PGP-peptide on ethanol-induced erosions and acetate-induced ulcers in rats].Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology, , Issue:4, 2004
Secretory activity of mast cell during stress: effect of prolyl-glycyl-proline and Semax.Bulletin of experimental biology and medicine, , Volume: 136, Issue:4, 2003
A mechanism for matrikine regulation in acute inflammatory lung injury.JCI insight, , 04-08, Volume: 6, Issue:7, 2021
Abnormal pro-gly-pro pathway and airway neutrophilia in pediatric cystic fibrosis.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, , Volume: 19, Issue:1, 2020
Proline-Glycine-Proline Peptides Are Critical in the Development of Smoke-induced Emphysema.American journal of respiratory cell and molecular biology, , Volume: 61, Issue:5, 2019
Benzyloxycarbonyl-proline-prolinal (ZPP): Dual complementary roles for neutrophil inhibition.Biochemical and biophysical research communications, , 10-01, Volume: 517, Issue:4, 2019
An extracellular matrix fragment drives epithelial remodeling and airway hyperresponsiveness.Science translational medicine, , 08-22, Volume: 10, Issue:455, 2018
The neutrophil chemoattractant peptide proline-glycine-proline is associated with acute respiratory distress syndrome.American journal of physiology. Lung cellular and molecular physiology, , 11-01, Volume: 315, Issue:5, 2018
The development of novel LTAScientific reports, , 03-17, Volume: 7, 2017
Matrikines are key regulators in modulating the amplitude of lung inflammation in acute pulmonary infection.Nature communications, , Sep-24, Volume: 6, 2015
A Potential Role for Acrolein in Neutrophil-Mediated Chronic Inflammation.Inflammation, , Volume: 38, Issue:6, 2015
Airway collagen and elastic fiber content correlates with lung function in equine heaves.American journal of physiology. Lung cellular and molecular physiology, , Aug-01, Volume: 307, Issue:3, 2014
Binding of Pro-Gly-Pro at the active site of leukotriene A4 hydrolase/aminopeptidase and development of an epoxide hydrolase selective inhibitor.Proceedings of the National Academy of Sciences of the United States of America, , Mar-18, Volume: 111, Issue:11, 2014
Cigarette smoke-induced collagen destruction; key to chronic neutrophilic airway inflammation?PloS one, , Volume: 8, Issue:1, 2013
Tripeptide Pro-Gly-Pro prevents disturbances in osmotic resistance of rat erythrocytes under conditions of inflammation.Bulletin of experimental biology and medicine, , Volume: 153, Issue:3, 2012
A self-propagating matrix metalloprotease-9 (MMP-9) dependent cycle of chronic neutrophilic inflammation.PloS one, , Jan-13, Volume: 6, Issue:1, 2011
A critical role for LTA4H in limiting chronic pulmonary neutrophilic inflammation.Science (New York, N.Y.), , Oct-01, Volume: 330, Issue:6000, 2010
Medicine. Neutrophils find smoke attractive.Science (New York, N.Y.), , Oct-01, Volume: 330, Issue:6000, 2010
Matrix metalloproteinase-8 facilitates neutrophil migration through the corneal stromal matrix by collagen degradation and production of the chemotactic peptide Pro-Gly-Pro.The American journal of pathology, , Volume: 173, Issue:1, 2008
A novel proteolytic cascade generates an extracellular matrix-derived chemoattractant in chronic neutrophilic inflammation.Journal of immunology (Baltimore, Md. : 1950), , Apr-15, Volume: 180, Issue:8, 2008
Reply to 'A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation'.Nature medicine, , Volume: 12, Issue:6, 2006
The multifaceted roles of the matrikine Pro-Gly-Pro in pulmonary health and disease.European respiratory review : an official journal of the European Respiratory Society, , Jun-30, Volume: 27, Issue:148, 2018
Leukotriene A4 hydrolase: an anti-inflammatory role for a proinflammatory enzyme.Thorax, , Volume: 66, Issue:6, 2011
Targeting of a common receptor shared by CXCL8 and N-Ac-PGP as a therapeutic strategy to alleviate chronic neutrophilic lung diseases.European journal of pharmacology, , Sep-30, Volume: 667, Issue:1-3, 2011
A critical role for LTA4H in limiting chronic pulmonary neutrophilic inflammation.Science (New York, N.Y.), , Oct-01, Volume: 330, Issue:6000, 2010
Medicine. Neutrophils find smoke attractive.Science (New York, N.Y.), , Oct-01, Volume: 330, Issue:6000, 2010
A critical role for LTA4H in limiting chronic pulmonary neutrophilic inflammation.Science (New York, N.Y.), , Oct-01, Volume: 330, Issue:6000, 2010
Medicine. Neutrophils find smoke attractive.Science (New York, N.Y.), , Oct-01, Volume: 330, Issue:6000, 2010
Feasibility and physiological relevance of designing highly potent aminopeptidase-sparing leukotriene A4 hydrolase inhibitors.Scientific reports, , 10-19, Volume: 7, Issue:1, 2017
A critical role for LTA4H in limiting chronic pulmonary neutrophilic inflammation.Science (New York, N.Y.), , Oct-01, Volume: 330, Issue:6000, 2010
Medicine. Neutrophils find smoke attractive.Science (New York, N.Y.), , Oct-01, Volume: 330, Issue:6000, 2010
Glyprolines exert protective and repair-promoting effects in the rat stomach: potential role of the cytokine GRO/CINC-1.Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, , Volume: 67, Issue:2, 2016
Correlation analysis of cytokine gene expression changes and antiulcer effects of Pro-Gly-Pro and N-Acetyl-Pro-Gly-Pro in experimental models of ulceration.Doklady. Biochemistry and biophysics, , Volume: 465, 2015
Effect of glyprolines on homeostasis of gastric mucosa in rats with stress ulcers.Bulletin of experimental biology and medicine, , Volume: 149, Issue:1, 2010
[Protective effect of the intraperitoneal and intragastric administration of PGP-peptide on ethanol-induced erosions and acetate-induced ulcers in rats].Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology, , Issue:4, 2004
[Protective effect of peptide PGP on gastric mucosa].Doklady Akademii nauk, , Volume: 368, Issue:5, 1999
[Effects of glyprolines on development and healing of acetate ulcers in rats].Patologicheskaia fiziologiia i eksperimental'naia terapiia, , Issue:2
Safety/Toxicity (1)
Pharmacokinetics (1)
Bioavailability (2)